- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07679022
Recovery With Virtual Reality for Stress and Pain (ReVRS)
Recovery With Virtual Reality for Stress & Pain (ReVRS)
Descripción general del estudio
Estado
Intervención / Tratamiento
Descripción detallada
Preoperative anxiety and postoperative pain may negatively affect patients' recovery after surgery. Virtual reality may provide a non-pharmacological method of distraction and relaxation, but its effect on perioperative anxiety and early postoperative recovery requires further evaluation.
This prospective, randomized, parallel-group controlled trial will include approximately 140 adults undergoing elective gynecological surgery. After providing informed consent, participants will be randomized in a 1:1 ratio to one of two groups:
- Virtual reality plus usual perioperative care.
- Usual perioperative care alone.
Participants assigned to the intervention group will use a virtual reality headset for approximately 10-20 minutes before surgery and view an immersive relaxation environment. The intervention may be discontinued at any time if the participant experiences discomfort, nausea, dizziness, anxiety, or other adverse symptoms.
The primary outcome is the change in preoperative anxiety from immediately before to immediately after the intervention period, assessed using the State-Trait Anxiety Inventory-State scale and/or a numerical rating scale for anxiety.
Secondary outcomes include quality of recovery measured with the Quality of Recovery-15 questionnaire, postoperative pain measured using a numerical rating scale, opioid consumption expressed as morphine milligram equivalents, postoperative nausea and vomiting, time spent in the postoperative care unit, and other indicators of early postoperative recovery. Follow-up assessments are planned at approximately 24 and 72 hours and on postoperative days 7 and 10.
The study will examine whether preoperative virtual reality reduces anxiety and whether any reduction is associated with improved postoperative recovery and reduced symptom burden.
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Pether Jildenstål, Professor
- Número de teléfono: +46 76-026 66 58
- Correo electrónico: pether.jildenstal@med.lu.se
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- Adults aged 18 years or older.
- Scheduled to undergo elective gynecological surgery according to the study protocol at a participating center where virtual reality can be provided.
- Able and willing to provide informed consent for study participation, 1:1 randomization, and use of virtual reality.
Exclusion Criteria:
- Increased risk of adverse effects related to virtual reality, including pronounced motion sickness, claustrophobia, or photosensitive epilepsy.
- Active substance use disorder or active misuse of alcohol or illicit drugs.
- Severe chronic pain and/or regular preoperative opioid treatment, as defined in the study protocol.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Virtual Reality Plus Usual Care
Participants receive a preoperative virtual reality session in addition to usual perioperative care.
The session lasts approximately 10-20 minutes and is delivered in the waiting or preoperative area using calm nature or relaxation scenes intended to promote comfort and distraction.
|
A single preoperative virtual reality session lasting approximately 10-20 minutes, administered in the waiting or preoperative area.
Participants view calm nature, relaxation, or guided-breathing scenes using a virtual reality headset.
The intervention is intended to provide relaxation, comfort, and distraction before surgery.
|
|
Comparador activo: Usual Care
Participants receive usual perioperative care without virtual reality during the corresponding preoperative period.
|
Participants receive standard perioperative care according to local clinical routines.
No preoperative virtual reality session is provided during the corresponding intervention period.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Quality of Postoperative Recovery Measured With QoR-15
Periodo de tiempo: 24 hours after surgery
|
Postoperative recovery will be assessed using the 15-item Quality of Recovery questionnaire (QoR-15).
The total score ranges from 0 to 150, with higher scores indicating better quality of recovery.
|
24 hours after surgery
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Preoperative Anxiety
Periodo de tiempo: From immediately before to immediately after the intervention, approximately 10-20 minutes
|
Anxiety will be assessed before and after the preoperative intervention period using the anxiety measure specified in the study protocol.
Higher scores indicate greater anxiety.
|
From immediately before to immediately after the intervention, approximately 10-20 minutes
|
|
Postoperative Pain Intensity
Periodo de tiempo: Up to 72 hours after surgery
|
Postoperative pain will be assessed using a numerical rating scale from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain.
|
Up to 72 hours after surgery
|
|
Postoperative Opioid Consumption
Periodo de tiempo: During the first 24 hours after surgery
|
Total postoperative opioid consumption will be calculated and converted to intravenous morphine milligram equivalents.
|
During the first 24 hours after surgery
|
|
Incidence of Postoperative Nausea and Vomiting
Periodo de tiempo: During the first 24 hours after surgery
|
Number and proportion of participants experiencing nausea, vomiting, or both during the postoperative period.
|
During the first 24 hours after surgery
|
|
Duration of Stay in the Post-Anesthesia Care Unit
Periodo de tiempo: On the day of surgery
|
Time from admission to discharge from the post-anesthesia care unit.
|
On the day of surgery
|
|
Quality of Recovery at 72 Hours Measured With QoR-15
Periodo de tiempo: 72 hours after surgery
|
Quality of postoperative recovery will be assessed using the 15-item Quality of Recovery questionnaire (QoR-15).
The total score ranges from 0 to 150, with higher scores indicating better quality of recovery.
|
72 hours after surgery
|
|
Quality of Recovery on Postoperative Day 7 Measured With QoR-15
Periodo de tiempo: 7 days after surgery
|
Quality of postoperative recovery will be assessed using the 15-item Quality of Recovery questionnaire (QoR-15).
The total score ranges from 0 to 150, with higher scores indicating better quality of recovery.
|
7 days after surgery
|
|
Quality of Recovery on Postoperative Day 10 Measured With QoR-15
Periodo de tiempo: 10 days after surgery
|
Quality of postoperative recovery will be assessed using the 15-item Quality of Recovery questionnaire (QoR-15).
The total score ranges from 0 to 150, with higher scores indicating better quality of recovery.
|
10 days after surgery
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 2026-03077-01 (Otro identificador: Swedish Ethical Review Authority)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .